A prostate cancer drug developed by Medivation Inc and Astellas Pharma Inc has been approved by the U.S. Food and Drug Administration for treating men whose cancer has stopped responding to hormone therapy and chemotherapy
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment